PetIQ (PETQ) Change In Receivables

: $-24 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

PetIQ's change in receivables for the quarter that ended in Dec. 2023 was $8 Mil. It means PetIQ's Accounts Receivable declined by $8 Mil from Sep. 2023 to Dec. 2023 .

PetIQ's change in receivables for the fiscal year that ended in Dec. 2023 was $-24 Mil. It means PetIQ's Accounts Receivable increased by $24 Mil from Dec. 2022 to Dec. 2023 .

PetIQ's Accounts Receivable for the quarter that ended in Dec. 2023 was $127 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PetIQ's Days Sales Outstanding for the three months ended in Dec. 2023 was 52.63.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PetIQ's liquidation value for the three months ended in Dec. 2023 was $-354 Mil.

PetIQ Change In Receivables Historical Data

The historical data trend for PetIQ's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetIQ Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-14.12

-31.65

-11.20

-4.14

-24.46

PetIQ Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables																7.08	-84.25	9.78	41.91	8.11

PetIQ Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24 Mil.

PetIQ (NAS:PETQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PetIQ's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	126.835	/	219.926	*	91
=	52.63

2. In Ben Graham's calculation of liquidation value, PetIQ's accounts receivable are only considered to be worth 75% of book value:

PetIQ's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	116.369	-	645.228	+	0.75 * 126.835	+	0.5 * 159.309
=	-354

PetIQ Change In Receivables Related Terms

Thank you for viewing the detailed overview of PetIQ's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

PetIQ (PETQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PetIQ Inc (NAS:PETQ) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

39L:Germany

Address

230 East Riverside Drive, Eagle, ID, USA, 83616

Website

https://www.petiq.com

PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time were primarily available from veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.

Executives

William J. Carter	officer: EVP, GENERAL COUNSEL	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
John Paul Pearson	officer: EVP, Services & Manufactured	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Robert Michael Herrman	officer: General Counsel and Secretary	923 SOUTH BRIDGEWAY PLACE, EAGLE ID 83616
Michael A Smith	officer: EVP - Products	923 S. BRIDGEWAY PLACE, C/O PETIQ, INC., EAGLE ID 83616
Kimberly Lefko	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Sheryl Oloughlin	director	923 S. BRIDGEWAY PLACE, EAGLE ID 83616
Scott Huff	director	923. S. BRIDGEWAY PLACE, EAGLE ID 83616
Allan Hall	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Zvi Glasman	officer: Chief Financial Officer	C/O FOX FACTORY HOLDING CORP., 915 DISC DRIVE, SCOTTS VALLEY CA 95066
Kenneth C. Walker	director	C/O PETIQ, INC., 230 E. RIVERSIDE DR., EAGLE ID 83616
Susan Sholtis	director	C/O PETIQ, INC., 500 E. SHORE DRIVE, SUITE 120, EAGLE ID 83616
Mccord Christensen	director, officer: Chief Executive Officer	500 EAST SHORE DRIVE, SUITE 120, EAGLE ID 83616
John Newland	officer: Chief Financial Officer	C/O TRUE SCIENCE LLC, 500 E. SHORE DRIVE SUITE 120, EAGLE ID 83616
Ronald Kennedy	director, 10 percent owner	500 EAST SHORE DR, SUITE 120, EAGLE ID 83616
Ecp Helios Partners Iv, L.p.	10 percent owner	437 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10022